SP1 and hepatocellular carcinoma: In conclusion, our study demonstrates that miR-324-5p suppresses hepatocellular carcinoma cell invasion by attenuate the expression and activity of MMP2 and MMP9, subsequently counteracting ECM degradation, through post-transcriptionally downregulating ETS1 and SP1.